The number of Xarelto lawsuits in federal court jumped by nearly 500 over the month of August. There are currently over 1,700 Xarelto lawsuits consolidated in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana, and if recent court records are anything to go by, the number will continue to increase rapidly in the coming months.
Xarelto is a blood-thinning drug approved by the U.S. Food and Drug Administration (FDA) to help prevent blood clotting in patients who have undergone a certain surgery or have an irregular heartbeat. With over 11 million unique prescriptions in the United States, Xarelto is one of the most popular anticoagulants on the market. However, Xarelto has been linked to episodes of severe bleeding in adverse event reports and medical studies.
Plaintiffs who have filed Xarelto lawsuits claim the drug’s manufacturers (Janssen Pharmaceuticals and Bayer HealthCare, among others) misled patients in saying their drug was a safer alternative to older oral anticoagulants like Warfarin. The situation is exacerbated by the fact that Xarelto has no approved cure for severe bleeding, unlike Warfarin, which can be counteracted with Vitamin K and plasma infusions.
Speak to your doctor if you have any concerns about your medications. Did you or someone close to you suffer severe bleeding after taking Xarelto? If so, you may be eligible to join the fast-growing Xarelto multidistrict litigation. Contact Lopez McHugh now for a free consultation with one of our qualified attorneys and find out whether a Xarelto lawsuit may be right for you.
